Dr. Dadu on Treatment Options for Thyroid Cancer

Ramona Dadu, MD
Published: Friday, Mar 17, 2017



Ramona Dadu, MD, assistant professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, discusses treatment options for patients with anaplastic thyroid cancer.

There are approved treatments but they are not particularly effective, explains Dadu. Therefore, clinical trials have been used as first-line therapy for patients with metastatic anaplastic thyroid cancer.

Right now, targeted therapy holds the hope for being the next approach for treatment for these patients but there is also interest in the combination of targeted therapy with immunotherapy, states Dadu.
 
SELECTED
LANGUAGE


Ramona Dadu, MD, assistant professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, discusses treatment options for patients with anaplastic thyroid cancer.

There are approved treatments but they are not particularly effective, explains Dadu. Therefore, clinical trials have been used as first-line therapy for patients with metastatic anaplastic thyroid cancer.

Right now, targeted therapy holds the hope for being the next approach for treatment for these patients but there is also interest in the combination of targeted therapy with immunotherapy, states Dadu.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients With Graft-Versus-Host DiseaseMar 28, 20192.0
2017 Year in Review™: Clinical Impact of Immunotherapies in the Treatment of CancerMar 30, 20191.75
Publication Bottom Border
Border Publication
x